JPS6155514B2 - - Google Patents

Info

Publication number
JPS6155514B2
JPS6155514B2 JP53107869A JP10786978A JPS6155514B2 JP S6155514 B2 JPS6155514 B2 JP S6155514B2 JP 53107869 A JP53107869 A JP 53107869A JP 10786978 A JP10786978 A JP 10786978A JP S6155514 B2 JPS6155514 B2 JP S6155514B2
Authority
JP
Japan
Prior art keywords
carbostyryl
reaction
formula
propoxy
general formula
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
JP53107869A
Other languages
English (en)
Japanese (ja)
Other versions
JPS5535019A (en
Inventor
Takao Nishi
Kazuyuki Nakagawa
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Otsuka Pharmaceutical Co Ltd
Original Assignee
Otsuka Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=14470137&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=JPS6155514(B2) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Otsuka Pharmaceutical Co Ltd filed Critical Otsuka Pharmaceutical Co Ltd
Priority to JP10786978A priority Critical patent/JPS5535019A/ja
Priority to CA000334272A priority patent/CA1139761A/en
Priority to DE19792934747 priority patent/DE2934747A1/de
Priority to PH22976A priority patent/PH18452A/en
Priority to US06/070,710 priority patent/US4277479A/en
Priority to AR277883A priority patent/AR229342A1/es
Priority to AU50397/79A priority patent/AU538410B2/en
Priority to FI792699A priority patent/FI68398C/fi
Priority to NLAANVRAGE7906523,A priority patent/NL183888C/xx
Priority to DK363179A priority patent/DK158788C/da
Priority to SU792804457A priority patent/SU1064868A3/ru
Priority to ES483792A priority patent/ES483792A1/es
Priority to FR7921869A priority patent/FR2434809A1/fr
Priority to PT70136A priority patent/PT70136A/pt
Priority to MX798357U priority patent/MX6749E/es
Priority to IT68748/79A priority patent/IT1119929B/it
Priority to CH792079A priority patent/CH641799A5/de
Priority to BE0/196976A priority patent/BE878548A/xx
Priority to NO792829A priority patent/NO153177C/no
Priority to ZA00794627A priority patent/ZA794627B/xx
Priority to SE7907236A priority patent/SE432252B/sv
Priority to GB7930520A priority patent/GB2033893B/en
Priority to AT0584579A priority patent/AT364363B/de
Publication of JPS5535019A publication Critical patent/JPS5535019A/ja
Publication of JPS6155514B2 publication Critical patent/JPS6155514B2/ja
Granted legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D257/00—Heterocyclic compounds containing rings having four nitrogen atoms as the only ring hetero atoms
    • C07D257/02—Heterocyclic compounds containing rings having four nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • C07D257/04—Five-membered rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/08—Bronchodilators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Pulmonology (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Hospice & Palliative Care (AREA)
  • Cardiology (AREA)
  • Psychiatry (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
JP10786978A 1978-09-01 1978-09-01 Carbostyryl derivative Granted JPS5535019A (en)

Priority Applications (23)

Application Number Priority Date Filing Date Title
JP10786978A JPS5535019A (en) 1978-09-01 1978-09-01 Carbostyryl derivative
CA000334272A CA1139761A (en) 1978-09-01 1979-08-22 Tetrazolylalkoxycarbostyril derivatives and process for producing the same
DE19792934747 DE2934747A1 (de) 1978-09-01 1979-08-28 Tetrazolylalkoxycarbostyrilderivate, verfahren zu deren herstellung und arzneimittel, welche diese enthalten
AU50397/79A AU538410B2 (en) 1978-09-01 1979-08-29 Tetrazolyl alkoxy carbostyril derivatives
US06/070,710 US4277479A (en) 1978-09-01 1979-08-29 Tetrazolylalkoxycarbostyril derivatives and pharmaceutical compositions containing them
PH22976A PH18452A (en) 1978-09-01 1979-08-29 Novel tetrayolylakoxy carbostyril derivatives
AR277883A AR229342A1 (es) 1978-09-01 1979-08-29 Procedimiento para obtener derivados de(5-tetrazolilalquilenoxi)-carboestirilo o 3,4-dihidrocarboestirilo y procedimiento para preparar 5-haloalquilen-tetrazol de aplicacion exclusiva como reactivo en dicho procedimiento
FI792699A FI68398C (fi) 1978-09-01 1979-08-30 Foerfarande foer framstaellning av nya terapeutiskt anvaendbara tetrazolylalkoxikarbostyrilderivat
NLAANVRAGE7906523,A NL183888C (nl) 1978-09-01 1979-08-30 Carbostyrilderivaat met een remmende werking op de aggregatie van bloedplaatjes, werkwijze ter bereiding van deze derivaten, farmaceutisch preparaat dat een dergelijk derivaat bevat en werkwijze ter bereiding van dergelijke farmaceutische preparaten.
DK363179A DK158788C (da) 1978-09-01 1979-08-30 Analogifremgangsmaade til fremstilling af tetrazolylalkoxycarbostyrilderivater
SU792804457A SU1064868A3 (ru) 1978-09-01 1979-08-30 Способ получени тетразолилалкоксикарбостирилов
SE7907236A SE432252B (sv) 1978-09-01 1979-08-31 Tetrazolyl-alkoxi-karbostyrilderivat
NO792829A NO153177C (no) 1978-09-01 1979-08-31 Analogifremgangsmaate for fremstilling av farmakologisk aktive tetrazolylalkoksy-karbostyrilderivater.
ES483792A ES483792A1 (es) 1978-09-01 1979-08-31 Un procedimiento para la preparacion de derivados de tetra- zolilalcoxicarbostirilo.
PT70136A PT70136A (en) 1978-09-01 1979-08-31 Novel tetrazolylalkoxycarbostyril derivatives and process for producing the same
MX798357U MX6749E (es) 1978-09-01 1979-08-31 Procedimiento para la preparacion de derivados de tetrazolilalcoxicarboestirilo
IT68748/79A IT1119929B (it) 1978-09-01 1979-08-31 Derivati del tetrazolil alcossi carbostirile e procedimento per la loro fabbricazione
CH792079A CH641799A5 (de) 1978-09-01 1979-08-31 Tetrazolylalkoxycarbostyrilderivate, verfahren zu ihrer herstellung und diese enthaltende arzneimittel.
BE0/196976A BE878548A (fr) 1978-09-01 1979-08-31 Nouveaux derives de tetrazolylalcoxycarbostyrile, procede pour leur preparation et leurs applications en therapeutique
FR7921869A FR2434809A1 (fr) 1978-09-01 1979-08-31 Nouveaux derives de tetrazolylalcoxycarbostyrile, procede pour leur preparation et leurs applications en therapeutique
ZA00794627A ZA794627B (en) 1978-09-01 1979-08-31 Novel tetrazolylalkoxycarbostyril derivatives and process for producing the same
AT0584579A AT364363B (de) 1978-09-01 1979-09-03 Verfahren zum herstellen neuer tetrazolylalkoxycarbostyrilderivate
GB7930520A GB2033893B (en) 1978-09-01 1979-09-03 Tetrazolylalkoxycarbostyril derivatives

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP10786978A JPS5535019A (en) 1978-09-01 1978-09-01 Carbostyryl derivative

Publications (2)

Publication Number Publication Date
JPS5535019A JPS5535019A (en) 1980-03-11
JPS6155514B2 true JPS6155514B2 (enExample) 1986-11-28

Family

ID=14470137

Family Applications (1)

Application Number Title Priority Date Filing Date
JP10786978A Granted JPS5535019A (en) 1978-09-01 1978-09-01 Carbostyryl derivative

Country Status (23)

Country Link
US (1) US4277479A (enExample)
JP (1) JPS5535019A (enExample)
AR (1) AR229342A1 (enExample)
AT (1) AT364363B (enExample)
AU (1) AU538410B2 (enExample)
BE (1) BE878548A (enExample)
CA (1) CA1139761A (enExample)
CH (1) CH641799A5 (enExample)
DE (1) DE2934747A1 (enExample)
DK (1) DK158788C (enExample)
ES (1) ES483792A1 (enExample)
FI (1) FI68398C (enExample)
FR (1) FR2434809A1 (enExample)
GB (1) GB2033893B (enExample)
IT (1) IT1119929B (enExample)
MX (1) MX6749E (enExample)
NL (1) NL183888C (enExample)
NO (1) NO153177C (enExample)
PH (1) PH18452A (enExample)
PT (1) PT70136A (enExample)
SE (1) SE432252B (enExample)
SU (1) SU1064868A3 (enExample)
ZA (1) ZA794627B (enExample)

Families Citing this family (70)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS57156469A (en) * 1981-03-19 1982-09-27 Otsuka Pharmaceut Co Ltd Preparation of tetrazole derivative
JPS57183761A (en) * 1981-04-30 1982-11-12 Otsuka Pharmaceut Co Ltd Carbostyril derivative
JPS5859980A (ja) * 1981-10-05 1983-04-09 Otsuka Pharmaceut Co Ltd カルボスチリル誘導体
JPS5877880A (ja) * 1981-11-05 1983-05-11 Otsuka Pharmaceut Co Ltd テトラゾ−ル誘導体
DE3225169A1 (de) * 1982-07-06 1984-01-12 Basf Ag, 6700 Ludwigshafen Chinolinderivate, verfahren zu ihrer herstellung, diese enthaltende mikrobizide und ihre verwendung zur bekaempfung von pilzen
US4803162A (en) * 1984-05-15 1989-02-07 Fluorodiagnostic Limited Partners Composition, article and process for detecting a microorganism
PT80533B (en) * 1984-05-29 1987-04-06 Pfizer Process for preparing quinolone inotropic agents
GB8529362D0 (en) * 1985-11-28 1986-01-02 Pfizer Ltd Quinolone cardiac stimulants
DK167187A (da) * 1986-04-02 1987-10-03 Otsuka Pharma Co Ltd Carbostyrilderivater og salte deraf, fremgangsmaade til fremstilling af saadanne forbindelser og laegemiddel indeholdende disse
JPH0681752B2 (ja) * 1986-04-02 1994-10-19 大塚製薬株式会社 カルボスチリル誘導体
JPH0681727B2 (ja) * 1986-04-02 1994-10-19 大塚製薬株式会社 血小板粘着抑制剤
KR940000785B1 (ko) * 1986-04-02 1994-01-31 오오쓰까세이야꾸 가부시끼가이샤 카르보스티릴 유도체 및 그의 염의 제조 방법
JP2753622B2 (ja) 1988-05-02 1998-05-20 大塚製薬株式会社 カルボスチリル誘導体
US5064837A (en) * 1989-11-13 1991-11-12 Schering Corporation 3-substituted-1-aryl-2(h)-quinolones and their pharmaceutical compositions
ES2067920T3 (es) * 1990-01-08 1995-04-01 Otsuka Pharma Co Ltd Tonico para el cabello y composicion acondicionadora.
TW201305B (enExample) * 1991-04-03 1993-03-01 Otsuka Pharma Co Ltd
CA2093633A1 (en) * 1991-08-23 1993-02-24 Seiji Sato Carbostyril derivative and platelets aggregation inhibitory agent
JPH0776521A (ja) * 1993-09-07 1995-03-20 Otsuka Pharmaceut Co Ltd 気道炎症抑制剤
US6187790B1 (en) 1999-03-04 2001-02-13 Neal R. Cutler Use of cilostazol for treatment of sexual dysfunction
US20030045547A1 (en) 2001-05-02 2003-03-06 Shinji Aki Process for producing carbostyril derivatives
JP4060523B2 (ja) * 1999-11-24 2008-03-12 大塚製薬株式会社 カルボスチリル誘導体の製造法
US6515128B2 (en) 2000-03-20 2003-02-04 Teva Pharmaceutical Industries Ltd. Processes for preparing cilostazol
US6525201B2 (en) 2000-03-20 2003-02-25 Teva Pharmaceutical Industries, Ltd. Processes for preparing 6-hydroxy-3,4-dihydroquinolinone, cilostazol and N-(4-methoxyphenyl)-3-chloropropionamide
US6825214B2 (en) 2000-08-14 2004-11-30 Teva Pharmaceutical Industries, Ltd. Substantially pure cilostazol and processes for making same
CZ2003667A3 (cs) * 2000-08-14 2003-08-13 Teva Pharmaceutical Industries Ltd. Způsob výroby cilostazolu
US6458804B1 (en) * 2001-01-26 2002-10-01 R.T. Alamo Venturesi, Llc Methods for the treatment of central nervous system disorders in certain patient groups
US6451813B1 (en) 2001-01-26 2002-09-17 R. T. Alamo Ventures I, Llc Treatment of gastroparesis in certain patient groups
US20050101631A1 (en) * 2002-08-01 2005-05-12 Otsuka Pharmaceuticals Company Process for producing carbostyril derivatives
US7399864B2 (en) * 2001-05-02 2008-07-15 Otsuka Pharmaceutical Co., Ltd. Process for producing carbostyril derivatives
JP2003063965A (ja) * 2001-06-13 2003-03-05 Otsuka Pharmaceut Factory Inc 注射用シロスタゾール水性製剤
US6388080B1 (en) 2001-06-29 2002-05-14 Grayson Walker Stowell Polymorphic forms of 6-[4-(1-cyclohexyl-1H-tetrazol-5-yl)butoxy]-3,4-dihydro-2(1H)-quinolinone
US6660864B2 (en) * 2001-06-29 2003-12-09 Grayson Walker Stowell Polymorphic forms of 6-[4-(1-cyclohexyl-1H-tetrazol-5-yl)butoxy]-3,4-dihydro-2(1H)-quinolinone
US6573382B2 (en) * 2001-06-29 2003-06-03 Grayson Walker Stowell Polymorphic forms of 6-[4-(1-cyclohexyl-1H-tetrazol-5-yl)butoxy]-3,4-dihydro-2(1H)-quinolinone
WO2003002121A1 (en) * 2001-06-29 2003-01-09 Aaipharma, Inc. Polymorphic forms of 6-[4-(1-cyclohexyl-1h-tetrazol-5-yl)butoxy]-3, 4-dihydro-2(1h)-quinolinone
US6657061B2 (en) * 2001-06-29 2003-12-02 Grayson Walker Stowell Polymorphic forms of 6-[4-1(1-cyclohexyl-1H-tetrazol-5-yl)butoxy]-3,4-dihydro-2(1H)-quinolinone
AU2002322456A1 (en) * 2001-06-29 2003-03-03 Aaipharma, Inc. Polymorphic forms of 6-(4-(1-cyclohexyl-1h-tetrazol-5-yl)butoxy)-3, 4-dihydro-2(1h)-quinolinone
US6531603B1 (en) * 2001-06-29 2003-03-11 Grayson Walker Stowell Polymorphic forms of 6-[4-(1-cyclohexyl-1H-tetrazol-5-yl)butoxy]-3,4-dihydro-2(1H)-quinolinone
US6596871B2 (en) * 2001-06-29 2003-07-22 Grayson Walker Stowell Polymorphic forms of 6-[4-(1-cyclohexyl-1h-tetraol-5-yl)butoxy]-3,4-dihydro-2(1H)-quinolinone
EP1489080B1 (en) * 2002-09-10 2011-01-26 Otsuka Pharmaceutical Co., Ltd. Process for producing cilostazol
US6743806B2 (en) * 2002-10-23 2004-06-01 Otsuka Pharmaceutical Company, Limited Active oxygen scavenger
US7772188B2 (en) 2003-01-28 2010-08-10 Ironwood Pharmaceuticals, Inc. Methods and compositions for the treatment of gastrointestinal disorders
TWI323660B (en) * 2003-02-25 2010-04-21 Otsuka Pharma Co Ltd Pten inhibitor or maxi-k channels opener
ITMI20031670A1 (it) * 2003-08-26 2005-02-27 Dinamite Dipharma S P A In Forma A Bbreviata Diph Processo per la preparazione di cilostazolo e di suoi intermedi.
US7524960B2 (en) * 2004-03-16 2009-04-28 Chemagis Ltd. Highly pure cilostazol and an improved process for obtaining same
US20050255155A1 (en) * 2004-05-11 2005-11-17 Glenmark Pharmaceuticals Limited Modified release cilostazol compositions
EP1802304A1 (en) * 2004-09-17 2007-07-04 Ranbaxy Laboratories Limited Cilostazol-containing pharmaceutical composition based on particles of less than 50 micrometers
CN100462360C (zh) * 2005-08-15 2009-02-18 上海立科药物化学有限公司 N-环己基-5-(4-氯丁基)-1h-四氮唑的合成方法
EP1942895B1 (en) 2005-09-15 2012-02-01 Otsuka Pharmaceutical Co., Ltd. Combination drug containing probucol and a tetrazolylalkoxy-dihydrocarbostyril derivative with superoxide supressant effects
US20070105898A1 (en) * 2005-11-09 2007-05-10 Apotex Pharmachem Inc. Process for the production of cilostazol
AR065588A1 (es) 2007-03-09 2009-06-17 Otsuka Pharma Co Ltd Un medicamento para tratar enfermedad pulmonar obstructiva cronica
TW200848041A (en) 2007-03-30 2008-12-16 Otsuka Pharma Co Ltd A medicament for treating schizophrenia comprising cilostazol
US8349817B2 (en) 2007-04-25 2013-01-08 Concert Pharmaceuticals, Inc. Analogues of cilostazol
ES2401914T3 (es) 2007-04-25 2013-04-25 Concert Pharmaceuticals Inc. Análogos de Cilostazol
MX2009012583A (es) 2007-05-22 2010-03-08 Otsuka Pharma Co Ltd Un medicamento que comprende un derivado de carbostirilo y donepezilo para tratar enfermedad de alzheimer.
WO2008151257A2 (en) 2007-06-04 2008-12-11 Synergy Pharmaceuticals Inc. Agonists of guanylate cyclase useful for the treatment of gastrointestinal disorders, inflammation, cancer and other disorders
US8969514B2 (en) 2007-06-04 2015-03-03 Synergy Pharmaceuticals, Inc. Agonists of guanylate cyclase useful for the treatment of hypercholesterolemia, atherosclerosis, coronary heart disease, gallstone, obesity and other cardiovascular diseases
ES2627848T3 (es) 2008-06-04 2017-07-31 Synergy Pharmaceuticals Inc. Agonistas de la guanilato ciclasa útiles para el tratamiento de trastornos gastrointestinales, inflamación, cáncer y otros trastornos
ES2624828T3 (es) 2008-07-16 2017-07-17 Synergy Pharmaceuticals Inc. Agonistas de la guanilato ciclasa útiles para el tratamiento de trastornos gastrointestinales, inflamación, cáncer y otros
EP2194048A1 (en) * 2008-12-02 2010-06-09 Dirk Sartor Nitrate esters for the treatment of vascular and metabolic diseases
WO2011158110A2 (en) 2010-04-28 2011-12-22 Nuformix Limited Cilostazol cocrystals and compositions
US9616097B2 (en) 2010-09-15 2017-04-11 Synergy Pharmaceuticals, Inc. Formulations of guanylate cyclase C agonists and methods of use
MX357121B (es) 2011-03-01 2018-06-27 Synergy Pharmaceuticals Inc Star Proceso de preparacion de agonistas c de guanilato ciclasa.
EP2958577A2 (en) 2013-02-25 2015-12-30 Synergy Pharmaceuticals Inc. Guanylate cyclase receptor agonists for use in colonic cleansing
EP2968439A2 (en) 2013-03-15 2016-01-20 Synergy Pharmaceuticals Inc. Compositions useful for the treatment of gastrointestinal disorders
US9708367B2 (en) 2013-03-15 2017-07-18 Synergy Pharmaceuticals, Inc. Agonists of guanylate cyclase and their uses
PL3004138T3 (pl) 2013-06-05 2024-07-29 Bausch Health Ireland Limited Ultra-oczyszczeni agoniści peptydowi cyklazy guanylanowej C, sposób ich uzyskiwania i ich zastosowanie
CA2920856C (en) 2013-08-09 2026-03-03 Ardelyx, Inc. Ph modulating compounds for inhibiting gastrointestinal phosphate uptake
JP2022533251A (ja) 2019-05-21 2022-07-21 アルデリックス， インコーポレイテッド 患者において血清リン酸塩を低下させるための組み合わせ
CN119350296B (zh) * 2023-07-24 2026-06-30 南京宁丹新药技术股份有限公司 一类取代的喹啉酮类衍生物及其用途
CN121108107A (zh) * 2024-06-05 2025-12-12 南京宁丹新药技术股份有限公司 一类喹啉类化合物及其用途

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2470084A (en) * 1945-09-25 1949-05-17 Bilhuber Inc E Substituted alpha-halogen alkyl tetrazoles and process for obtaining the same
US2470085A (en) * 1947-03-07 1949-05-17 Bilhuber Inc E Substituted amino alkyl tetrazoles
AR207554A1 (es) * 1972-12-02 1976-10-15 Otsuka Pharma Co Ltd Procedimiento para producir derivados de 3-alquil-5-((3,4-dihidro-5-carbostiril)oximetil)-oxazolidinona-(2)
JPS5310986B2 (enExample) * 1974-02-05 1978-04-18
JPS5310989B2 (enExample) * 1974-04-25 1978-04-18
FI59246C (fi) * 1974-06-24 1981-07-10 Otsuka Pharma Co Ltd Foerfarande foer framstaellning av benscykloamidderivat anvaendbara vid trombos- och emboliterapin
FI58329C (fi) * 1974-11-08 1981-01-12 Otsuka Pharma Co Ltd Foerfarande foer framstaellning av i 8-staellning substituerade 5-(3'-alkylamino-2'-hydroxi)propoxi-3,4-dihydrokarbostyrilderivat
US4129565A (en) * 1975-07-11 1978-12-12 Nisshin Flour Milling Co., Ltd. Isocarbostyril derivatives
US4210753A (en) * 1976-03-17 1980-07-01 Otsuka Pharmaceutical Co., Ltd. Carbostyril compounds
JPS52116482A (en) * 1976-03-24 1977-09-29 Otsuka Pharmaceut Co Ltd Carbostyril derivatives and its preparation
JPS5430183A (en) * 1977-08-10 1979-03-06 Otsuka Pharmaceut Co Ltd 3,4-dihydrocarbostyril derivative

Also Published As

Publication number Publication date
NO153177C (no) 1986-01-29
IT1119929B (it) 1986-03-19
DE2934747A1 (de) 1980-03-13
FI792699A7 (fi) 1980-03-02
CH641799A5 (de) 1984-03-15
SE7907236L (sv) 1980-03-02
CA1139761A (en) 1983-01-18
DK363179A (da) 1980-03-02
DK158788B (da) 1990-07-16
FR2434809A1 (fr) 1980-03-28
PT70136A (en) 1979-09-01
GB2033893A (en) 1980-05-29
GB2033893B (en) 1982-12-01
NL7906523A (nl) 1980-03-04
JPS5535019A (en) 1980-03-11
AU538410B2 (en) 1984-08-16
DK158788C (da) 1990-12-10
IT7968748A0 (it) 1979-08-31
FR2434809B1 (enExample) 1982-09-17
ZA794627B (en) 1980-08-27
NO792829L (no) 1980-03-04
SE432252B (sv) 1984-03-26
AT364363B (de) 1981-10-12
FI68398C (fi) 1985-09-10
MX6749E (es) 1986-06-25
NO153177B (no) 1985-10-21
AU5039779A (en) 1980-03-06
DE2934747C2 (enExample) 1988-01-28
AR229342A1 (es) 1983-07-29
NL183888C (nl) 1989-02-16
US4277479A (en) 1981-07-07
BE878548A (fr) 1979-12-17
FI68398B (fi) 1985-05-31
PH18452A (en) 1985-07-18
ATA584579A (de) 1981-03-15
ES483792A1 (es) 1980-09-01
SU1064868A3 (ru) 1983-12-30

Similar Documents

Publication Publication Date Title
JPS6318588B2 (enExample)
US4296034A (en) Polyfluorinated sulfonamides
DE69327890T2 (de) Verfahren zur Herstellung von 2-(un)substituierten 4-Alkylimidazolen
US4632999A (en) Process for the preparation of oxiranes
JP2731853B2 (ja) トリ低級アルカノイルオキシホウ素の製造法
JPH0124152B2 (enExample)
JPH0250110B2 (enExample)
FR2696745A1 (fr) Procédé de préparation de dérivés de phényltétrazole.
US3128286A (en) Process for preparing analogues
JPS5910351B2 (ja) ３−オキシ−１，２，４−トリアゾ−ル誘導体の製造方法
JPS6366318B2 (enExample)
EP0119091B1 (en) 2,2-diethoxypropionic acid derivatives
Singh et al. Synthesis and characterisation of some novel indeno [1, 2-c] pyrazoles
JPH02292263A (ja) １―メチル―３―アルキル―５―ピラゾールカルボン酸エステル類の製造法
US2567839A (en) 4 methoxyphenyl ester of 4-chloro-benzene sulfonic acid
US3478133A (en) Cyclic phosphate esters and process for producing same
US2567008A (en) Aryl esters of 4-chlorobenzene sulfonic acid
US4681943A (en) 1-acyl-1-(2-pyridinyl)semicarbazides
JPS59205365A (ja) ４―アセチル―２―置換―イミダゾール化合物の製造方法
US4065466A (en) Integrated process for the preparation of 2-dialkoxyphosphinylimino-1,3-dithietane
KR830000634B1 (ko) N-트리틸 이미다졸 화합물을 제조하는 방법
US3541158A (en) 1-(di(lower alkoxy)-4-alkylphenyl)-2-nitropropenes
US4147876A (en) Easily hydrolyzable esters of 4-(2-carboxyethyl)phenyl trans-4-aminomethylcyclohexanecarboxylate and process of use
US4946959A (en) Method of preparing 5-alkyl-1-(2-pyridinyl)-1H-1,2,4-triazol-3-ols
KR810001324B1 (ko) 티아졸린 유도체의 제조방법